Immunomedics, Inc.
Company Information

300 The American Rd
Morris Plains, NJ, 07950 United States
(973) 605-8200

Immunomedics, Inc. Rankings

Russell 2000 (June 2015)

Top 3 Competitors

Unlock more access to Hoover’s!

  • Build customized email lists 24/7, based on your best customer profile.
  • Learn more about the companies you want to sell to. Hoover’s has reports on 85+ million companies and 900 industries. 65,000 data points are updated each day.
  • Get real insight written by real people – exclusive research and reviews by our in-house Editorial staff.
  • We can deliver our data to your desktop, to Excel, direct to your CRM, into your custom app, or via mobile.

Call (866) 473-3932 today to get started with a FREE TRIAL!


Immunomedics, Inc. Company Profile

Immunomedics is a MAb scientist, mixing up monoclonal antibody (MAb) medicines to treat cancer, autoimmune conditions, and other diseases. Its lead product, epratuzumab, is in development for the treatment of lupus; biopharmaceutical firm UCB has licensed the drug for further applications in autoimmune diseases, but is exiting that partnership. Immunomedics is also conducting clinical trials for epratuzumab as an oncology treatment for non-Hodgkin's lymphoma. Other drugs in clinical trials aim to treat various cancers, including pancreatic cancer and multiple myeloma. It also makes diagnostic imaging products; its majority-owned IBC Pharmaceuticals develops radiotherapeutics for applications in oncology treatments.